Search results

Order by most recent / most popular / relevance

Results: 1-7 of 7

Dispelling the Myriad gene patent harmonization myth

Foley & Lardner LLP
-
Australia, Canada, European Union, France, Germany, Japan, USA
-
April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

European unitary patent: what does it mean for Canadians?

Gowling Lafleur Henderson LLP
-
Canada, European Union
-
December 17 2012

On December 11, 2012, the European Parliament approved a legislative package that is aimed at establishing a single, unified European patent system

Life sciences & law current issues 201213

Gowling Lafleur Henderson LLP
-
Canada, European Union, USA
-
June 18 2012

Each stage of the life cycle of a company or a product presents challenges that demand the expertise and resources of a strong legal partner

Biosimilar battlegrounds - what is new in biosimilars and where?

Bereskin & Parr LLP
-
Canada, European Union, USA
-
February 17 2012

Biosimilars are second entry biologic drugs

Europe discards embryonic stem cell patents

Bereskin & Parr LLP
-
Canada, European Union
-
December 15 2011

Adult stem cells, and processes for their manipulation, are generally patentable in Europe

Double patenting in Canada, the United States and Europe

Gowling Lafleur Henderson LLP
-
Canada, European Union, USA
-
June 28 2011

Double patenting refers to the granting of two patents for a single invention in the same country to the same patentee

Europe wants Canada to update patent laws

Gowling Lafleur Henderson LLP
-
Canada, European Union
-
March 15 2011

Canada is currently negotiating a comprehensive economic trade agreement with the European Union to increase the volume of trade and business occurring between Canada and Europe

Search results

Dispelling the Myriad gene patent harmonization myth

European unitary patent: what does it mean for Canadians?

Life sciences & law current issues 201213

Biosimilar battlegrounds - what is new in biosimilars and where?

Europe discards embryonic stem cell patents

Double patenting in Canada, the United States and Europe

Europe wants Canada to update patent laws

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea